Significant difference was observed in the frequency of ACE II, ID genotypes when comparing T2DM without dyslipidemia with controls (P<0.001, P=0.007) and T2DM with dyslipidemia (P<0.001, P<0.001). This evidence concerns the gene ACE and metabolic syndrome.